...
...
Next Story

Delhi surgeons remove football-sized tumour from Russian man’s chest

Updated on: Aug 19, 2017, 21:22:20 IST
Hindustan Times | By , New Delhi
Prefer HTon Google
Emil Abdullaev, 39, had a tumour weighing 3.2kg in his chest cavity. (HT Photo)
Emil Abdullaev, 39, had a tumour weighing 3.2kg in his chest cavity. (HT Photo)
Advertisement

Only about 5% of such tumours turn cancerous later on, say doctors.

In a four-hour-long surgery, a football-sized tumour weighing 3.2kg was removed from the chest cavity of a Russian man in a city hospital earlier this month.

Cancer surgeons at Fortis Hospital in Vasant Kunj performed what they call a ‘very risky’ surgery that required meticulous planning and surgical precision to avoid any complications as the tumour was touching main vessels that supplied blood to the heart and other vital organs.

The risk of death was so high that surgeons in Russia had to abort the surgery midway, fearing the procedure could prove fatal for the 39-year-old Emil Abdullaev.

“He was also turned down by several hospitals in India because of the location and size of tumour,” says Dr Sabyasachi Bal, director, thoracic onco surgery at Fortis, who operated upon him.

Abdullaev was suffering for the past five years from breathlessness and immense discomfort, following which he underwent a series of tests.

The tests revealed that a giant tumor was gradually growing in his chest cavity, exerting tremendous pressure on his right lung.

The tumour originated from the lining of the chest wall called the pleura. Pleural tumours are found in the pleural space, the cavity between the lungs and chest wall that contains lubricating pleural fluid.

There is always a risk of complication later on if the tumour is not excised completely, and also a possibility that affected lung may not regain full functionality.

“It is a complicated surgery, no doubt, but we are 100% sure of having taken out the entire tumour. He is doing fine and should be able to lead a normal life,” said Dr Bal.

Abdullaev was admitted at Fortis on July 31, and operated on August 1. He was discharged on August 8.

 
ABOUT THE AUTHOR
Rhythma Kaul

Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.

Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
SHARE THIS ARTICLE ON